Cancer Survival Rates Hit 70%: A Milestone, But Progress is at Risk
For the first time ever, the five-year survival rate for all cancers combined has reached 70% in the United States, a landmark achievement detailed in the American Cancer Society’s (ACS) Cancer Statistics, 2026 report. This means that seven out of ten people diagnosed with cancer between 2015 and 2021 are still alive five years later. But this hard-won progress faces a looming threat: potential cuts to federal research funding and healthcare access.
The Dramatic Shift in Survival: Where Are We Seeing the Biggest Gains?
The improvement isn’t uniform across all cancers. The most significant gains are being seen in cancers historically considered the most deadly, and in those diagnosed at a later stage. For example, survival rates for multiple myeloma have jumped from 32% to 62%, while liver cancer has seen an increase from 7% to 22%. Even advanced-stage cancers like metastatic melanoma (16% to 35%) and metastatic lung cancer (2% to 10%) are showing encouraging improvements.
These gains are largely attributed to three key factors: reductions in smoking rates, earlier detection through screening programs, and advancements in cancer treatment. Consider the case of immunotherapy, a relatively new approach that harnesses the body’s own immune system to fight cancer. It’s revolutionized treatment for melanoma, lung cancer, and other malignancies.
Pro Tip: Regular screenings are crucial for early detection. Talk to your doctor about which screenings are appropriate for you based on your age, family history, and risk factors.
Disparities Remain: A Stark Reality for Native American Communities
Despite the overall positive trend, significant disparities persist. The ACS report highlights a particularly concerning statistic: Native American individuals experience the highest cancer mortality rates, with death rates roughly double those of White individuals for several common cancers, including kidney, liver, stomach, and uterine cancers. They also face the highest rates of lung cancer mortality. These disparities are often linked to factors like limited access to healthcare, socioeconomic challenges, and environmental exposures.
The Rising Tide of Cancer Incidence: Why We Can’t Afford to Slow Down
While mortality rates are declining, the Cancer Statistics, 2026 report also reveals a worrying trend: the incidence of many common cancers is increasing. Cases of breast, prostate, liver (in women), melanoma (in women), oral cavity, pancreatic, and uterine corpus cancers are all on the rise. This increase is likely due to a combination of factors, including an aging population, lifestyle changes, and improved diagnostic capabilities.
Did you know? Cancer is the second leading cause of death in the United States overall, but it’s the leading cause of death for individuals under the age of 85.
The Threat to Progress: Federal Funding Cuts and Their Potential Impact
The researchers behind the ACS report are sounding the alarm about proposed federal cuts to cancer research and health insurance. They warn that these cuts could reverse the progress made over decades and jeopardize future breakthroughs. Shane Jacobson, CEO of the ACS and ACS Cancer Action Network, emphasizes that federal funding has been instrumental in driving advancements in cancer treatment and improving survival rates.
“We can’t stop now,” Jacobson stated. “There is still much work to be done.” Reduced funding could lead to slower development of new therapies, limited access to clinical trials, and ultimately, a higher cancer death toll.
Cancer in Younger Populations: A Growing Concern
The report also sheds light on the impact of cancer on younger individuals. Cancer is the second most common cause of death among children aged 1 to 14 (after accidents) and the fourth most common cause of death among adolescents aged 15 to 19. Leukemia remains the most prevalent childhood cancer, accounting for 28% of cases, closely followed by central nervous system tumors (27%).
Frequently Asked Questions (FAQ)
Q: What is the 5-year survival rate?
A: The 5-year survival rate is the percentage of people diagnosed with cancer who are still alive five years after their diagnosis.
Q: Why are cancer incidence rates increasing even though mortality rates are decreasing?
A: This is likely due to a combination of factors, including an aging population, lifestyle changes, and improved diagnostic capabilities leading to earlier detection.
Q: What can I do to reduce my risk of cancer?
A: You can reduce your risk by maintaining a healthy lifestyle, including not smoking, eating a balanced diet, exercising regularly, and getting regular screenings.
Q: Where can I find more information about cancer statistics?
A: You can find more information on the American Cancer Society website (https://www.cancer.org/) and in the full Cancer Statistics, 2026 report (https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70043).
Reader Question: “I’m worried about my family history of cancer. What should I do?”
A: Discuss your family history with your doctor. They can help you assess your risk and recommend appropriate screening and prevention strategies.
Take Action: Share this article with your friends and family to raise awareness about cancer statistics and the importance of continued research funding. Advocate for cancer research funding and support organizations like the American Cancer Society.
Keep reading